Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 24/06/14

Trade details

Type
Insider sale
Amount
$321,581.52
Shares · price
1,118 sh · $287.64 a share
Held after
130 sh
Trade date
24/06/13
Filed
24/06/14
Days to filing
1 days

Sold 89.6% of holdings

Share of holding sold
89.6%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/14~24/07/13

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $262.3K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $321.6K of United Therapeutics UTHR · 89.6% of holdings · 10b5-1 plan | Whalegun